Adveritas Limited (AU:AV1) has released an update. Adveritas Limited has released a presentation providing general information about the ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

We’re having this realization in the industry" that law firm partners won't be able to have financial literacy "through ...

We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalised lists.